All Drug
Common Medicines
Oncology
Hematology
Hepatology
Chronic Diseases
Department of Endocrinology
Orphan drugs
Tumor area
Drug selection
Medical Information
-
Precautions for taking terbotinib: monitoring of edema, pulmonary, hepatic, and pancreatic toxicity
Although terbotinib is a targeted d...
2026-09-03 16:18:12 -
Taboo population of terbotinib: liver and kidney dysfunction, pregnancy and breastfeeding precautions
Not all patients are suitable for u...
2026-09-03 16:13:48 -
Management of side effects of terbotinib: coping with diarrhea, nausea, and fatigue
Adverse reactions during treatment ...
2026-09-03 16:09:40 -
Tepotinib Usage Guidelines: With Meal, Dosage, and Omission Management
To ensure efficacy and safety, plea...
2026-09-03 15:47:54 -
Precautions for taking Luketinib: risk of infection, thrombocytopenia, hepatotoxicity, and non melanoma skin cancer
During the treatment of diseases su...
2026-09-02 16:46:42 -
Ruxolitinib taboo population: instructions for active severe infection and non screened tuberculosis patients
Ruxolitinib, as a JAK inhibitor, ca...
2026-09-02 16:45:10 -
Management of side effects of Luketinib: How to deal with dizziness, bruising, and weight gain
Lucretinib may cause side effects s...
2026-09-02 16:43:17 -
Ruxolitinib medication guide: on an empty stomach or with meals? Dose adjustment and treatment of missed doses
The standardized use of Ruxolitinib...
2026-09-02 16:41:37